Xanax XR 3 mg tablets recalled for failed dissolution specifications
Viatris is recalling one lot of Xanax XR (alprazolam) 3 mg extended-release tablets because they failed to meet dissolution specifications—meaning the tablets may not break down and release the medication properly in your body. This affects only lot #8177156 with an expiration date of 02/28/2027, distributed nationwide. No injuries have been reported.
From the FDA notice · Read the official notice ↗
What to do
- Check if your Xanax XR 3 mg bottle has lot #8177156 and expiration date 02/28/2027
- If it matches, contact your pharmacy or prescriber before stopping the medication
- Do not stop taking alprazolam abruptly without medical guidance, as it can cause serious withdrawal symptoms
- Your pharmacist can verify the lot number on your bottle label
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Illnesses reported
- None reported
- Manufactured in
- 1000 Mylan Blvd, Canonsburg, PA, United States
- Classification
- Class II
- Recall number
- D-0444-2026
In the FDA's words
- Description
- Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91 Failed Dissolution Specifications Lot# 8177156, Exp Date: 02/28/2027 Distribution: US Nationwide.
- Hazard
- Failed Dissolution Specifications
More from Viatris
- Viatris telmisartan/amlodipine tablets recalled for superpotency risk
ModerateFDAOct 16, 2026